Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis

I. Hojsak, V. Colomb, C. Braegger, J. Bronsky, C. Campoy, M. Domellöf, N. Embleton, N. Fidler Mis, JM. Hulst, F. Indrio, A. Lapillonne, W. Mihatsch, C. Molgaard, J. van Goudoever, M. Fewtrell, . ,

. 2016 ; 62 (5) : 776-92.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, metaanalýza, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18011304

The aim of the present article was to perform a systematic review with meta-analysis of available scientific evidence regarding the role of different intravenous lipid emulsions (ILE) in the pathogenesis of cholestasis and parenteral nutrition-associated liver disease. A systematic review of the literature (up to March 2015) identified 23 randomized controlled trials (RCTs). Of these, 17 were performed in preterm infants or critically ill neonates with a short duration of intervention, 2 in older children with short-term use (following surgery or bone marrow transplantation), 1 in neonates with long-term use, and 3 in infants and children receiving long-term parenteral nutrition (PN). Meta-analysis showed no differences in the rate of cholestasis or bilirubin levels associated with short-term use of different ILEs. Because of high heterogeneity of the long-term studies no meta-analysis could be performed. Available studies found that the use of multicomponent fish oil (FO)-containing ILE compared with pure soya bean oil (SO), ILE-reduced liver enzymes, and bilirubin levels in noncholestatic children on long-term PN and one other RCT found that FO-based ILE-reversed cholestasis in a proportion of patients. The ESPGHAN Committee on Nutrition concludes that there is no evidence of a difference in rates of cholestasis or bilirubin levels between different ILE for short-term use in neonates. The use of multicomponent FO-containing ILE may contribute to a decrease in total bilirubin levels in children with IF on prolonged PN. Well-designed RCTs are, however, lacking and long-term effects have not been determined.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18011304
003      
CZ-PrNML
005      
20180404142724.0
007      
ta
008      
180404s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/MPG.0000000000001121 $2 doi
035    __
$a (PubMed)26825766
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Hojsak, Iva $u *University Children's Hospital Zagreb, Zagreb, Croatia †Paris, France ‡University Children's Hospital, Zurich, Switzerland §Department of Paediatrics, University Hospital Motol, Prague, Czech Republic ||Department of Paediatrics, University of Granada, Granada, Spain ¶Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden #Newcastle Neonatal Service, Newcastle Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, UK **Department of Gastroenterology, Hepatology and Nutrition, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia ††Department of Pediatric Gastroenterology, Erasmus MC, Sophia Children's Hospital, Rotterdam, The Netherlands ‡‡Pediatric Gastroenterology Division, Ospedale Pediatrico Giovanni XXIII, University of Bari, Bari, Italy §§Paris Descartes University, APHP Necker-Enfants Malades Hospital, Paris, France ||||CNRC, Baylor College of Medicine, Houston, TX ¶¶Harlaching Hospital Department of Pediatrics, Munich Municipal Hospitals, Munich, Germany ##Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen ***Pediatric Nutrition Unit, Copenhagen University Hospital, Rigshospitalet, Denmark †††Department of Pediatrics, VU University Medical Center, Amsterdam ‡‡‡Department of Pediatrics, Emma Children's Hospital-AMC, Amsterdam, The Netherlands §§§Childhood Nutrition Research Centre, UCL Institute of Child Health, London, UK.
245    10
$a ESPGHAN Committee on Nutrition Position Paper. Intravenous Lipid Emulsions and Risk of Hepatotoxicity in Infants and Children: a Systematic Review and Meta-analysis / $c I. Hojsak, V. Colomb, C. Braegger, J. Bronsky, C. Campoy, M. Domellöf, N. Embleton, N. Fidler Mis, JM. Hulst, F. Indrio, A. Lapillonne, W. Mihatsch, C. Molgaard, J. van Goudoever, M. Fewtrell, . ,
520    9_
$a The aim of the present article was to perform a systematic review with meta-analysis of available scientific evidence regarding the role of different intravenous lipid emulsions (ILE) in the pathogenesis of cholestasis and parenteral nutrition-associated liver disease. A systematic review of the literature (up to March 2015) identified 23 randomized controlled trials (RCTs). Of these, 17 were performed in preterm infants or critically ill neonates with a short duration of intervention, 2 in older children with short-term use (following surgery or bone marrow transplantation), 1 in neonates with long-term use, and 3 in infants and children receiving long-term parenteral nutrition (PN). Meta-analysis showed no differences in the rate of cholestasis or bilirubin levels associated with short-term use of different ILEs. Because of high heterogeneity of the long-term studies no meta-analysis could be performed. Available studies found that the use of multicomponent fish oil (FO)-containing ILE compared with pure soya bean oil (SO), ILE-reduced liver enzymes, and bilirubin levels in noncholestatic children on long-term PN and one other RCT found that FO-based ILE-reversed cholestasis in a proportion of patients. The ESPGHAN Committee on Nutrition concludes that there is no evidence of a difference in rates of cholestasis or bilirubin levels between different ILE for short-term use in neonates. The use of multicomponent FO-containing ILE may contribute to a decrease in total bilirubin levels in children with IF on prolonged PN. Well-designed RCTs are, however, lacking and long-term effects have not been determined.
650    _2
$a poradní výbory $7 D026683
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a cholestáza $x epidemiologie $x etiologie $7 D002779
650    _2
$a Evropa $x epidemiologie $7 D005060
650    _2
$a tukové emulze intravenózní $x aplikace a dávkování $x škodlivé účinky $x toxicita $7 D005217
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a jaterní testy $7 D008111
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a parenterální výživa $7 D010288
650    _2
$a randomizované kontrolované studie jako téma $7 D016032
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a metaanalýza $7 D017418
655    _2
$a přehledy $7 D016454
700    1_
$a Colomb, Virginie
700    1_
$a Braegger, Christian
700    1_
$a Bronsky, Jiri
700    1_
$a Campoy, Cristina
700    1_
$a Domellöf, Magnus
700    1_
$a Embleton, Nicholas
700    1_
$a Fidler Mis, Nataša
700    1_
$a Hulst, Jessie M
700    1_
$a Indrio, Flavia
700    1_
$a Lapillonne, Alexandre
700    1_
$a Mihatsch, Walter
700    1_
$a Molgaard, Christian
700    1_
$a van Goudoever, Johannes
700    1_
$a Fewtrell, Mary
700    1_
$a ,
773    0_
$w MED00010080 $t Journal of pediatric gastroenterology and nutrition $x 1536-4801 $g Roč. 62, č. 5 (2016), s. 776-92
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26825766 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180404142804 $b ABA008
999    __
$a ok $b bmc $g 1288789 $s 1008116
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 62 $c 5 $d 776-92 $i 1536-4801 $m Journal of pediatric gastroenterology and nutrition $n J Pediatr Gastroenterol Nutr $x MED00010080
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...